Buys
Open market- Shares
- Avg price
- Total value
Mark Strobeck - President and CEO, Director at ROCKWELL MEDICAL, INC.
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- RMTI on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Mark Strobeck in ROCKWELL MEDICAL, INC.
Sells
Open market- Shares
- -6,926
- Avg price
- $1.19
- Total value
- -$8,242
Net
Past year- Shares
- -6,926
- Share %
- -100%
- Total value
- -$8,242
Reported holdings for Mark Strobeck in ROCKWELL MEDICAL, INC.
Form 4 holding
President and CEO, Director
ROCKWELL MEDICAL, INC.
- Security class
- Common Stock
- Shares / value
- 62,349
- Estimated value
- $55,690
- Report date
- 01 Jul 2026
- Price
- $0.8932
- Ownership
- Direct
Form 4 holding
President and CEO, Director
ROCKWELL MEDICAL, INC.
- Security class
- Performance-based restricted stock units
- Shares / value
- 352,000
- Estimated value
- Report date
- 20 May 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President and CEO, Director
ROCKWELL MEDICAL, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 308,000
- Estimated value
- Report date
- 20 May 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Mark Strobeck in ROCKWELL MEDICAL, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.